Franklin Resources
CPRX

Franklin Resources’s Catalyst Pharmaceutical CPRX Stock Holding History

Franklin Resources’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76M Sell
119,516
-297,178
-71% -$8.77M ﹤0.01% 1744
2026
Q1 		$10.3M Buy
416,694
+262,757
+171% +$6.26M ﹤0.01% 1226
2025
Q4 		$3.59M Sell
153,937
-3,842
-2% -$85.6K ﹤0.01% 1552
2025
Q3 		$3.11M Buy
157,779
+17,597
+13% +$362K ﹤0.01% 1625
2025
Q2 		$3.04M Buy
140,182
+61,155
+77% +$1.44M ﹤0.01% 1557
2025
Q1 		$1.92M Buy
79,027
+20,544
+35% +$463K ﹤0.01% 1708
2024
Q4 		$1.22M Sell
58,483
-681
-1% -$14.6K ﹤0.01% 1901
2024
Q3 		$1.22M Buy
59,164
+1,967
+3% +$36.5K ﹤0.01% 1902
2024
Q2 		$886K Sell
57,197
-168,859
-75% -$2.63M ﹤0.01% 1975
2024
Q1 		$3.6M Buy
226,056
+40,133
+22% +$605K ﹤0.01% 1487
2023
Q4 		$3.13M Buy
185,923
+33,397
+22% +$457K ﹤0.01% 1251
2023
Q3 		$1.78M Buy
152,526
+28,327
+23% +$379K ﹤0.01% 1424
2023
Q2 		$1.67M Buy
124,199
+19,770
+19% +$285K ﹤0.01% 1470
2023
Q1 		$1.73M Buy
104,429
+394
+0.4% +$6.5K ﹤0.01% 1396
2022
Q4 		$1.94M Sell
104,035
-31,933
-23% -$492K ﹤0.01% 1371
2022
Q3 		$1.74M Sell
135,968
-382
-0.3% -$4.53K ﹤0.01% 1391
2022
Q2 		$956K Buy
136,350
+84,262
+162% +$618K ﹤0.01% 1550
2022
Q1 		$432K Buy
+52,088
New +$368K ﹤0.01% 1886
2016
Q1 		– Sell
-2,127,100
Closed -$5.21M – 1520
2015
Q4 		$5.21M Hold
2,127,100
– – ﹤0.01% 1123
2015
Q3 		$6.38M Sell
2,127,100
-384,500
-15% -$1.66M ﹤0.01% 1102
2015
Q2 		$10.4M Hold
2,511,600
– – ﹤0.01% 1032
2015
Q1 		$10.9M Hold
2,511,600
– – ﹤0.01% 1035
2014
Q4 		$7.46M Hold
2,511,600
– – ﹤0.01% 1105
2014
Q3 		$8.34M Sell
2,511,600
-77,900
-3% -$204K ﹤0.01% 1077
2014
Q2 		$6.55M Buy
+2,589,500
New +$5.53M ﹤0.01% 1137

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources's CPRX Position: Q2 2026 in Review

Franklin Resources reduced its Catalyst Pharmaceutical (CPRX) stake by 71% in Q2 2026, selling an estimated $8.77M and leaving 119,516 shares worth $3.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Franklin Resources first reported a position in CPRX in Q2 2014 and has held it in 25 quarters since. The position peaked at $10.9M in Q1 2015. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Franklin Resources held 119,516 shares of Catalyst Pharmaceutical worth $3.76M as of Q2 2026.
  • Franklin Resources sold 297,178 Catalyst Pharmaceutical shares in Q2 2026, an estimated $8.77M.
  • Catalyst Pharmaceutical made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1744 holding.
  • Franklin Resources first reported a position in Catalyst Pharmaceutical in Q2 2014 and has held it in 25 quarters since.
  • Franklin Resources's Catalyst Pharmaceutical position peaked at $10.9M in Q1 2015.
  • 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.